- ASO Visual Abstract: Log Odds of Positive Lymph Nodes Improves Risk Stratification for Early Recurrence and Survival After Radical Esophagectomy for cT3 Esophageal Squamous Cell Carcinoma. [Journal Article]Ann Surg Oncol. 2026 Aug 07. [Online ahead of print]AS
- Publisher Full Text (DOI)
- Assessing Graded Histological Regression as Basis for Treatment Modification after Neoadjuvant Therapy in LAGC: An Exploratory Phase II Study. [Journal Article]
- CONCLUSIONS: GHR < 50% may indicate the need to adjust adjuvant chemotherapy regimen in LAGC. A larger study is needed to validate its final survival impact.
- Publisher Full Text (DOI)
- De-escalation of Adjuvant EGFR-TKI in Stage IB EGFR-Mutated Non-small-cell Lung Cancer: A Real-World Study. [Journal Article]
- CONCLUSIONS: Despite the limitations of a retrospective design, our findings suggest that adjuvant EGFR-TKIs might be omitted in patients with stage IB NSCLC with tumors ≤ 3 cm, those with partial-solid tumors, or those without high-risk factors.
- Publisher Full Text (DOI)
- ASO Visual Abstract: Hepatectomy After Progressive Disease Following Chemotherapy for Colorectal Liver Metastases: A Japanese Nationwide Cohort Study. [Journal Article]Ann Surg Oncol. 2026 Aug 06. [Online ahead of print]AS
- Publisher Full Text (DOI)
- Association of Cancer Center Designation with Multimodality Treatment, Perioperative Outcomes, and Survival among Older Adults with Pancreatic Ductal Adenocarcinoma. [Journal Article]
- CONCLUSIONS: Compared with non-designated centers, care at NCI-designated centers was associated with greater use of multimodality therapy and improved survival among patients with stage I-III PDAC, whereas non-NCI CoC centers demonstrated outcomes that were generally closer to non-designated centers than to NCI-designated centers. These findings highlight the importance of access to centers delivering coordinated multimodality PDAC care.
- Publisher Full Text (DOI)
- ASO Visual Abstract: Baseline Liver Function Predicts Long-Term Survival Beyond Perioperative Outcomes After Liver Resection for Biliary Tract Cancer. [Journal Article]Ann Surg Oncol. 2026 Aug 06. [Online ahead of print]AS
- Publisher Full Text (DOI)
- ASO Visual Abstract: A Neuron Projection Guidance Signature Associates With Immune-Cold Tumor Microenvironment and Poor Outcomes in Breast Cancer. [Journal Article]Ann Surg Oncol. 2026 Aug 06. [Online ahead of print]AS
- Publisher Full Text (DOI)
- ASO Visual Abstract: Anatomic-Biologic Borderline Resectability Criteria Improve Recurrence Risk Stratification in Perihilar Cholangiocarcinoma. [Journal Article]Ann Surg Oncol. 2026 Aug 06. [Online ahead of print]AS
- Publisher Full Text (DOI)
- ASO Visual Abstract: Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer by Age, Race, and Tumor Subtype. [Journal Article]Ann Surg Oncol. 2026 Aug 05. [Online ahead of print]AS
- Publisher Full Text (DOI)
- ASO Visual Abstract: Preoperative Tumor-Informed ctDNA for Prediction of Nodal Metastases at Radical Cystectomy in Bladder Cancer. [Journal Article]Ann Surg Oncol. 2026 Aug 04. [Online ahead of print]AS
- Publisher Full Text (DOI)
- ASO Visual Abstract: Prognostic Relevance of Surgical Margins According to KRAS and BRAF Status in Colorectal Liver Metastases-BRAF-KRAS LiverMet Collaborative Group. [Journal Article]Ann Surg Oncol. 2026 Aug 04. [Online ahead of print]AS
- Publisher Full Text (DOI)
- Clinical and Functional Impact of CHMP3 in Pancreatic Ductal Adenocarcinoma. [Journal Article]
- CONCLUSIONS: CHMP3 expression is associated with poor outcomes in PDAC and may provide modest additional prognostic information when combined with conventional factors, although residual confounding by adjuvant therapy cannot be excluded. These findings support the biological relevance of CHMP3 and suggest that CHMP3 may represent a prognosis-associated marker requiring external validation.
- Publisher Full Text (DOI)
- ASO Editorial: Preoperative Systemic Therapy for Perihilar Cholangiocarcinoma. [Editorial]
- Publisher Full Text (DOI)